Delivery Order SPE2DB22D3401-SPE2DB25FT4NU

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,523.55 and a performance period through April 2025. The contract is not set aside and is for the supply of PRIORIX VIALS, which are likely pharmaceutical products. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.62 firm fixed-price contract is for the supply of PRIORIX VIALS, with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.42, is for the delivery of PRIORIX vials, a vaccine product. It is a firm fixed-price delivery order contract type, with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIORIX VIALS, a medical product, with a ceiling value of $18,540.20 and a period of performance through October 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded on October 28, 2024. The place of performance is Conshohocken, Pennsylvania....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,140.20, is for the delivery of PRIORIX VIALS, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the procurement of a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIORIX VIALS, a medical product, with a ceiling value of $2,121.27 and an ultimate completion date of March 18, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,141.30 firm fixed-price delivery order is for 4568335552 PRIORIX VIALS, with a performance period ending on May 23, 2025. The contract is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,271.00 fixed-price contract covers the supply of PRIORIX VIALS medical products, with a period of performance through March 18, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,395.00, is for the delivery of PRIORIX VIALS, a medical product. The contract is a Delivery Order under a Firm Fixed Price arrangement, with a period of performance running through May 23, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
This is a federal contract award valued at $25,365.00 from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of PRIORIX VIALS. The contract is a firm fixed price delivery order with an ultimate completion date of October 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply critical medical commodities, including medications, vaccines, and medical supplies, to support military...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT4NU
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PRIORIX VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,750.02 and a period of performance through June 13, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract, designated as SPE2DX, allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, will be responsible for delivering the PRIORIX VIALS to the place of performance in Conshohocken, PA.

Generated 9/14/25, 12:45 AM